lilly glp 1 oral A new chapter in GLP-1 treatment is here. Meet Foundayo™ by Eli Lilly, the first FDA-approved GLP-1, designed to support weight loss through a convenient once-daily approach. Prescription-only treatment, with instant Eli Lilly is confident about

According to the International Diabetes Federation, 537 million adults were living with diabetes in 2025 and by 2045, the number is projected to increase to 783 million, and the World Health Organization estimates that global obesity prevalence has almost tripled since 1975, and that more than 1.1 billion adults are now considered obese globally

USP sets official standards for dietary supplements

173-88, Ronkainen PHA, Kovanen V, Aln M, et al

Start by reviewing your insurers policy to understand their requirements

At 6 months, semaglutide reaches 10 to 14% while tirzepatide reaches 13 to 18%

If youre experiencing concerning symptoms of gastroparesis for an extended period of time, talk to your doctor or schedule an appointment with one of our GI specialists.